Tipentosin

Tipentosin
Nazivi
	Preferisani IUPAC naziv 5-[[[(1S,2S,3S)-2-hidroski-3-fenoksiciklopentil]amino]metil]-2-metil-6,7-dihidro-5H-1-benzotiofen-4-on
	Drugi nazivi 6,7-dihydro-5-(((2-hydroxy-3-phenoxycyclopentyl)amino)methyl)-2-methylbenzo(b)thiophen-4(5H)-one • MDL 19744A • MDL 19744A, (+-)-isomer • MDL-19,744A • UNII-1E3N5X9H1Y • 1E3N5X9H1Y • 95588-08-2 • CHEMBL2111148
Identifikacija
CAS broj	95588-08-2 ;
3D model (Jmol)	interaktivna slika;
PubChem C ID	126282;
UNII	1E3N5X9H1Y ;
	SMILES CC1=CC2=C(S1)CCC(C2=O)CNC3CCC(C3O)OC4=CC=CC=C4; ; ; ; ; ;
Svojstva
Hemijska formula	C21H25NO3S
Molarna masa	371,50 g·mol−1
	Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
	Reference infokutije

Tipentosin je antagonist alfa adrenergičkog receptora.^[3]

Reference[уреди | уреди извор]

^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
^ J R McCarthy; et al. (1985). „6,7-Dihydro-5-[[(cis-2-hydroxy-trans-3-phenoxycyclopentyl)amino] methyl]-2-methylbenzo[b]thiophen-4(5H)-one: a novel alpha 1-adrenergic receptor antagonist and renal vasodilator”. J Med Chem. 28 (9): 1142—5. doi:10.1021/jm00147a003.